Testing effectiveness (Phase 2)Study completedNCT00892775
What this trial is testing
Immunogenicity & Safety Study of GSK Biologicals' 208136 Vaccine Formulated With New Measles and Rubella Working Seeds
Who this might be right for
MeaslesVaricellaMumps+1 more
GlaxoSmithKline 501